Bristol-Myers Squibb Company
Agreement signed for sale of U.S., Canadian consumer medicines business
Published in Pharma Law Weekly, August 16th, 2005
Under the terms of the agreement, Novartis will acquire the trademarks, patents and intellectual property rights of the U.S. and Canadian Consumer Medicines business and related assets for $660 million, to be paid in cash at closing. The transaction is subject to customary regulatory approvals and is expected to close by the end of the third quarter. Bristol-Myers Squibb announced its intent to divest the business in January 2005.
The transaction includes...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly
Source: Pharma Law Weekly (2005-08-16)
More Articles from Pharma Law Weekly
- AlphaRx, Inc.
Antibiotic development program uses nanoparticle delivery platform - Amrad
U.S. patent granted for asthma treatment - Cardinal Health, Inc.
Prescription drug benefit is on the way for patients with limited income - Consumers Union
Voluntary advertising plan won't cut it, consumer group says - Dey, LP
Pharma company reaches settlement with Connecticut on pricing litigation - Informed Decisions
Collaboration formed to educate Medicaid beneficiaries on options - More from this issue of Pharma Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
